retatrutide study news today Today, we shared new data from the latest Phase 3 of retatrutide, an investigational treatment being studied for adults with obesity or overweight with at least one weight-related comorbidity. Learn more Perceived benefits of treatment for

Eli Lilly is targeting an FDA new drug application submission in late 2026, after TRIUMPH-1 is published

Orforglipron: A Breakthrough in Oral GLP-1 Small-Molecule Drug Development On April 1, 2026, Eli Lilly and Company announced that its oral small-molecule GLP-1 receptor agonist Orforglipron had received approval from the U.S

PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway analysis that maps 14 biological pathways, 49 peptides, and 150+ genetic insightsincluding your GLP1R and GIPR variants

Comprehensive Bio-Analysis We start with [Functional Blood Testing] to check your thyroid, cortisol, and insulin sensitivity

Seun Sowemimo, will ensure personalized weight loss and weight management care tailored to your needs

It is especially important to confirm that this therapy is safe and effective in conditions of insulin insensitivity and impaired insulin secretion